Popular Design for Zoledronic Acid Monohydrate - Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Purity >99.0% (HPLC) API Factory High Quality – Ruifu
Popular Design for Zoledronic Acid Monohydrate - Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Purity >99.0% (HPLC) API Factory High Quality – Ruifu Detail:
Supply Sitagliptin Phosphate Monohydrate Related Intermediates:
Sitagliptin API CAS 486460-32-6
Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid CAS 486460-00-8
Sitagliptin Triazole Hydrochloride CAS 762240-92-6
Sitagliptin Phosphate Monohydrate Intermediate CAS 486460-21-3
Chemical Name | Sitagliptin Phosphate Monohydrate |
Synonyms | (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate |
CAS Number | 654671-77-9 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C16H20F6N5O6P |
Molecular Weight | 523.3240802 |
Melting Point | 202.0~204.0℃ |
Water Solubility | Soluble in Water |
Specific Rotation | -18.0°~-23.0° (C=1, Water) |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Off-White Crystalline Powder |
Identification by HPLC | The retention time of sample is concordant with reference standard |
IR-Infrared Spectrum | The IR Absorption Spectrum of the sample shall be concordant with that of standard spectrum |
Phosphate | Complies |
Purity / Analysis Method | >99.0% (HPLC on the dried basis) |
Water Content (K.F) | 3.3%~4.4% |
Residue on Ignition | ≤0.20% |
Sulphate | ≤0.02% |
Chloride | ≤0.05% |
Chiral Impurity | <0.50% |
Related Substances | |
Single Impurity | <0.50% |
Total Impurities | <1.0% |
Ethyl Acetate | <0.50% |
Heavy Metals | <20ppm |
Test Standard | Enterprise Standard |
Usage | Pharmaceutical Intermediates |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.
Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9), a new drug for the treatment of type 2 diabetes. In August 2009, the drug was approved by the European Union as a first-line drug for the treatment of type 2 diabetes. Sitagliptin Phosphate is the first FDA-approved dipeptidyl peptidase-IV inhibitor to be used in the treatment of type 2 diabetes by far, under the trade name Januvia. Dipeptidylpeptidase Ⅳ (DPP-Ⅳ) rapidly and effectively degrades GLP-1, GLP-1, which is the most effective stimulator of insulin production and secretion Therefore, inhibition of DPP-IV can enhance the role of endogenous GLP-1, thereby increasing blood insulin levels, thereby reducing and maintaining blood glucose levels in diabetic patients. At present, medicine has confirmed that DPP-IV inhibitor is a new type of anti-diabetic drug, and clinical results show that the drugs have a good hypoglycemic effect. Because GLP-1 plays a glucose-dependent role in promoting insulin production and secretion, common adverse reactions such as hypoglycemia and weight gain caused by the use of antidiabetic drugs do not occur.
Product detail pictures:
Related Product Guide:
We have now numerous great personnel members good at advertising, QC, and working with kinds of troublesome dilemma from the creation course of action for Popular Design for Zoledronic Acid Monohydrate - Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Purity >99.0% (HPLC) API Factory High Quality – Ruifu , The product will supply to all over the world, such as: Cambodia, Saudi Arabia, St. Petersburg, Our mission is to deliver consistently superior value to our customers and their clients. This commitment permeates everything we do, driving us to continuously develop and improve our products and the processes to fulfill your needs.
By Dawn from Turkmenistan - 2018.11.28 16:25
The company can think what our think, the urgency of urgency to act in the interests of our position, can be said this is a responsible company, we had a happy cooperation!
By Sharon from Algeria - 2018.05.13 17:00